BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190216
DTEND;VALUE=DATE:20190320
DTSTAMP:20260729T200059
CREATED:20190216T201737Z
LAST-MODIFIED:20190216T201737Z
UID:21065-1550275200-1553039999@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:Postdoctoral Fellow\, Chemist/chemical biologist \nThere is an immediate opening for a Postdoctoral Fellow in the Qi group at the Dana-Farber Cancer Institute to look for exceptional Postdoctoral Fellows in Chemistry and Chemical Biology field. The Qi lab studies gene regulatory pathways using the emerging discipline of chemical biology. Successful candidates will work with an interdisciplinary team of scientists including medicinal chemists\, biochemists\, computational biologists\, and cancer biologists to develop novel inhibitors of chromatin modifying enzymes\, such as methyltransferases\, demethylases as well as other epigenetic targets and transcription factors. The successful candidate will perform research that establishes fundamental insights to cancer biology using novel small molecule inhibitors to gain mechanistic understanding in cancer therapy. We expect that novel therapeutics for human clinical investigation will emerge directly from these efforts through academic/industry collaborations. \nThe postdoctoral fellow will be affiliated with the Department of Cancer Biology at Dana-Farber Cancer Institute\, the Department of Medicine at Harvard Medical School and the Broad Institute. \n\n\n\nResponsibilities\n\n\n\nWe are seeking an enthusiastic\, self-motivated\, and experienced bench-level synthetic chemist who is willing to learn multi-discipline approach for cancer research to join our team. The major focus of this position will include developing and executing design and synthesis small molecule inhibitors while investigating novel biological mechanisms of action of inhibitors in cancer with team. \n\nPerforming synthesis and development of small molecule inhibitors under structure guidance.\nExperience in computational modeling is a plus.\nPerforming laboratory experiments and conducting data analysis.\nCollaborating with team members and collaborators to understand the target inhibition in different cancers.\nDesigning experiments and executing protocols.\nMaintaining accurate records\, writing reports\, and preparing/giving presentations.\nChemical biology/Biology background is preferred but not required.\n\n\n\n\nQualifications\n\n\n\n\nPhD in chemistry\, medicinal chemistry\, chemical biology or equivalent\nA strong understanding in biochemistry\, chromatin biology\, cancer biology is preferred\, but not required.\nExcellent oral and written communication skills.\nThe ability to perform both self-directed and guided research is required.\nMust demonstrate outstanding ability to work effectively as part of an interdisciplinary team of scientists.
URL:https://ces.b2sg.org/event/16feb19/
LOCATION:Dana-Farber Cancer Institute\, 450 Brookline Avenue\, Boston\, MA\, 02215\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Dana-Farber.jpg
END:VEVENT
END:VCALENDAR